Foresite Capital Fund II L.P. 13D/13G Filings for Aerie Pharmaceuticals, Inc. (AERI)

Foresite Capital Fund II L.P. 13D and 13G filings for Aerie Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-06-12
3:09 pm
Sale
2020-03-31 13G Aerie Pharmaceuticals, Inc.
AERI
Foresite Capital Fund II L.P. 837,907
1.800%
-4,686,684decrease
(-84.83%)
Filing